Open AccessRetrospective evaluation of the performance of the electrical impedance spectroscopy system Nevisense in detecting keratinocyte cancers
Author(s) -
Liebich Christoph,
Bruehl MarieLuise,
Schubert Irene,
Oberhoffer Renate,
Sander Christian
Publication year - 2021
Publication title -
skin research and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.521
H-Index - 69
eISSN - 1600-0846
pISSN - 0909-752X
DOI - 10.1111/srt.13007
Subject(s) - medicine , malignancy , retrospective cohort study , melanoma , dermatology , keratinocyte , radiology , surgery , pathology , cancer research , biochemistry , chemistry , in vitro
Background Keratinocyte cancers, also referred to as non‐melanoma skin cancers (NMSCs), are one of the most common malignant skin tumors. We performed a retrospective analysis of lesions from patients of a private dermatology practice to evaluate the use of electrical impedance spectroscopy (EIS) in detecting keratinocyte malignancies. The aim of the study is to assess the accuracy of the technique and to rate its use as supportive tool in NMSC diagnosis. Material and Methods The period evaluated ranges from September 2015 to November 2019. In total, 1712 lesions from 951 patients were included. All lesions suspicious for malignancy were gauged with the Nevisense device. Excised lesions were sent in for histopathological classification, and the results were compared to the Nevisense score. Results A total of 767 lesions (44.8%) received a negative score (0‐3) from the Nevisense system and 945 lesions (55.2%) a positive score (4‐10). The combination of the dermatologist's visual assessment plus the technical determined Neviscore resulted in the excision of 52.5% of all 1712 suspicious lesions whereof 15% were found to be malignant. The sensitivity of Nevisense was 98.4% for NMSC detection. Conclusion Electrical impedance spectroscopy was found to be a valuable adjunct support tool in clinical decisions for cases with suspicion for NMSC.